We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Biotechs (Regeneron and Amgen) also played a key role here. Ferguson looks for solid cash flows and strong balance sheets and likes to scoop up biotechs after their share prices decline.

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.